Kobayashi Pharmaceutical Co., Ltd.
KBYPF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $3 | $401 | $417 | $438 |
| - Cash | $0 | $56 | $52 | $51 |
| + Debt | $0 | $1 | $1 | $1 |
| Enterprise Value | $2 | $345 | $366 | $388 |
| Revenue | $0 | $36 | $33 | $51 |
| % Growth | -99.2% | 11.7% | -36.2% | – |
| Gross Profit | $0 | $19 | $17 | $25 |
| % Margin | 52% | 53.5% | 51.2% | 48.7% |
| EBITDA | $0 | $6 | $4 | $9 |
| % Margin | 16.7% | 17.4% | 13.8% | 16.9% |
| Net Income | $0 | $2 | $2 | $5 |
| % Margin | 8.5% | 4.2% | 5% | 9.2% |
| EPS Diluted | 0.33 | 20.76 | 21.85 | 63.53 |
| % Growth | -98.4% | -5% | -65.6% | – |
| Operating Cash Flow | – | $0 | $0 | $0 |
| Capital Expenditures | – | $0 | $0 | $0 |
| Free Cash Flow | – | $0 | $0 | $0 |